Cyclophosphamide Drug regimens prescribed for<unk>  include mycophenolate mofetil (MMF), intravenous cyclophosphamide with corticosteroids, and the immune suppressant azathioprine with corticosteroids. MMF and cyclophosphamide with corticosteroids are equally effective in achieving remission of the disease, however the results of a recent systematic review found that immunosuppressive drugs were better than corticosteroids for renal outcomes. MMF is safer than cyclophosphamide with corticosteroids, with less chance of causing ovarian failure, immune problems or hair loss. It also works better than azathioprine with corticosteroids for maintenance therapy. A 2016 network meta-analysis, which included 32 RCTs of<unk> , demonstrated that tacrolimus and MMF followed by azathioprine maintenance were associated with a lower risk of serious infection when compared to other immunosuppressants or glucocorticoids. Individuals with<unk>  have a high risk for B-cell lymphoma (which begins in the immune system cells).
Lupus nephritis
Shunt nephritis
Trench nephritis
Diffuse proliferative nephritis
Focal proliferative nephritis
HIV-associated nephropathy
Malarial nephropathy
IgA nephropathy